Results 201 to 210 of about 41,794 (337)

Metabolic bariatric surgery is associated with reduced adverse hepatic and extrahepatic outcomes, and lower all‐cause mortality, in patients with steatotic liver disease

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 174-185, January 2026.
Abstract Aim Metabolic bariatric surgery (MBS) improves histological endpoints in steatotic liver disease (SLD), but data on longer‐term clinical outcomes in this population are scarce. Here, we assessed the impact of MBS on hepatic and extrahepatic morbidity and mortality in individuals with SLD.
Weronika Stupalkowska, Alexander Henney, Eric G. Sheu, Uazman Alam, Daniel J. Cuthbertson   +4 more
wiley   +1 more source

Incremental benefits of catheter ablation in patients with structural heart disease undergoing implantable cardioverter-defibrillator therapy for ventricular arrhythmias: A PRISMA compliant systematic review and meta analysis. [PDF]

Medicine (Baltimore)
Amir M, Hassan A, Ali EF, Noor M, Nazir A, Kamran M, Rizwan A, Fahim MA, Usman M, Awais MN, Waleed M, Tahir MU, Khan MH, Haroon A.   +13 more
europepmc   +1 more source

RECURRENT VENTRICULAR TACHYCARDIA IN LATE ADULTHOOD FOLLOWING KAWASAKI DISEASE AS AN INFANT: COMPLEX DECISION-MAKING REGARDING ABLATION AND ANTIARRHYTHMIC THERAPY

Julio Ardura Fernández, Aria Kenarsary, Sunil K. Vasireddi   +2 more
openalex   +1 more source

Antiarrhythmic drug therapy for atrial fibrillation: Are the guidelines guiding clinical practice? [PDF]

, 2006
James A. Reiffel, Gerald V. Naccarelli
openalex   +1 more source

Risk of depression with GLP‐1 receptor agonists use in overweight or obese adults with type 2 diabetes: A new‐user, active‐comparator cohort study

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 197-209, January 2026.
Abstract Aims The association between glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and depression remains uncertain due to contradictory evidence. We compared the risk of incident depression between GLP‐1 RAs and sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) in overweight or obese adults with type 2 diabetes.
Yu Chang, Ming‐Hong Hsieh, Po‐Chung Ju, Cheng‐Chen Chang   +3 more
wiley   +1 more source

Diabetes Mellitus and Atrial Fibrillation: Mechanistic Insights and Therapeutic Impacts of Glucose-Lowering Drugs. [PDF]

Life (Basel)
Grigore M, Grigore AM, Ruxandra-Elena MG, Ioana V, Uscoiu G, Nicolae C, Balahura AM, Ilieșiu AM.   +7 more
europepmc   +1 more source

PCV6 THE COST COMPARISON OF CARDIOVERSION AND ANTIARRHYTHMIC THERAPY IN NONVALVULAR CHRONIC ATRIAL FIBRILLATION

, 2002
A Pietrasik, MM Latek, MP Niewada, Bogumił Kamiński, Dariusz A. Kosior   +4 more
openalex   +1 more source

Antiarrhythmic effect of cardiac resynchronization therapy with triple-site biventricular stimulation [PDF]

, 2013
Michio Ogano, Yu‐ki Iwasaki, Jun Tanabe, Hisato Takagi, Takuya Umemoto, Meiso Hayashi, Yasushi Miyauchi, Kyoichi Mizuno   +7 more
openalex   +1 more source

Effectiveness of direct oral anticoagulants for all‐cause mortality and cardiovascular events in overweight and obese patients with atrial fibrillation: Insight from the nationwide START registry

European Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
This study shows that overweight and obese patients with atrial fibrillation experience improved outcomes when treated with DOACs compared with VKAs. Specifically, DOAC use was associated with lower risks of all‐cause mortality and cardiovascular events.
Danilo Menichelli, Gianluca Gazzaniga, Emilia Antonucci, Gualtiero Palareti, Daniela Poli, Pasquale Pignatelli, Daniele Pastori, the START2 Register Investigators, Benilde Cosmi, Daniela Poli, Elena Lotti, Martina Berteotti, Walter Ageno, Giovanna Colombo, Salvatore Bradamante, Eugenio Bucherini, Monica Vastola, Paola Casasco, Antonio Chistolini, Alessandra Serrao, Luciano Crippa Ambulatorio Emostasi, Raimondo De Cristofaro, Erica De Candia, Valeria De Micheli, Marcello Di Nisio, Anna Falanga, Teresa Lerede, Elvira Grandone, Donatella Colaizzo, Antonio Insana, Nicola Lucio Liberato, Domenico Lione, Rosa Maria Lombardi, Giacomo Lucarelli, Giuseppe Malcangi, Catello Mangione, Giuliana Martini Centro Emostasi, Marco Marzolo, Giovanni Nante, Vincenzo Oriana, Paolo Pedico, Simona Pedrini, Vittorio Pengo, Antonietta Piana, Francesco Cibecchini, Simona Pezzella, Pasquale Pignatelli, Daniele Pastori, Vincenza Rossi, Lucia Ruocco, Paolo Chiarugi, Serena Rupoli, Domizio Serra, Carmine Spataro, Margherita Reduzzi, Sophie Testa, Oriana Paoletti, Vincenzo Toschi, Claudio Vasselli   +58 more
wiley   +1 more source

Emerging antiarrhythmic drug therapy for atrial fibrillation. [PDF]

Heart Rhythm O2
Lubitz SA, Taggart AKP, Gimpelewicz C, O'Donnell CJ.   +3 more
europepmc   +1 more source